Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chordoma | 10 | 2024 | 347 | 2.640 |
Why?
|
Sarcoma | 14 | 2024 | 1800 | 1.970 |
Why?
|
Osteosarcoma | 17 | 2023 | 896 | 1.930 |
Why?
|
Bone Neoplasms | 20 | 2023 | 2527 | 1.410 |
Why?
|
Carbolines | 2 | 2024 | 295 | 1.380 |
Why?
|
Neuregulin-1 | 5 | 2013 | 135 | 1.110 |
Why?
|
Fetal Proteins | 1 | 2024 | 98 | 0.910 |
Why?
|
Doxorubicin | 9 | 2024 | 2224 | 0.870 |
Why?
|
T-Box Domain Proteins | 1 | 2024 | 469 | 0.770 |
Why?
|
Liposarcoma | 5 | 2024 | 289 | 0.650 |
Why?
|
Sarcoma, Synovial | 4 | 2023 | 153 | 0.650 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 15 | 2024 | 11733 | 0.620 |
Why?
|
Spinal Neoplasms | 2 | 2022 | 703 | 0.600 |
Why?
|
RNA-Binding Protein EWS | 5 | 2024 | 210 | 0.600 |
Why?
|
Gastrointestinal Stromal Tumors | 1 | 2023 | 617 | 0.570 |
Why?
|
Cancer Vaccines | 2 | 2024 | 1038 | 0.550 |
Why?
|
Pyrimidines | 5 | 2023 | 3027 | 0.510 |
Why?
|
Chondrosarcoma | 3 | 2023 | 295 | 0.500 |
Why?
|
Antineoplastic Agents | 10 | 2023 | 13632 | 0.470 |
Why?
|
Receptor, erbB-2 | 4 | 2013 | 2553 | 0.470 |
Why?
|
Drug Resistance, Multiple | 4 | 2016 | 255 | 0.460 |
Why?
|
STAT3 Transcription Factor | 1 | 2018 | 872 | 0.440 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2024 | 1605 | 0.430 |
Why?
|
Pyridines | 7 | 2024 | 2872 | 0.430 |
Why?
|
Soft Tissue Neoplasms | 5 | 2022 | 1158 | 0.410 |
Why?
|
Combined Modality Therapy | 8 | 2024 | 8519 | 0.340 |
Why?
|
Leiomyosarcoma | 2 | 2024 | 422 | 0.330 |
Why?
|
MicroRNAs | 7 | 2020 | 3758 | 0.330 |
Why?
|
Furans | 2 | 2024 | 201 | 0.310 |
Why?
|
Drug Resistance, Neoplasm | 9 | 2023 | 5300 | 0.290 |
Why?
|
Glycine | 2 | 2020 | 659 | 0.270 |
Why?
|
Maximum Tolerated Dose | 3 | 2024 | 883 | 0.260 |
Why?
|
Benzamides | 2 | 2023 | 1371 | 0.260 |
Why?
|
Pancreatitis | 3 | 2022 | 1081 | 0.260 |
Why?
|
Myocytes, Cardiac | 4 | 2009 | 1666 | 0.250 |
Why?
|
RNA, Neoplasm | 3 | 2017 | 748 | 0.250 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 2 | 2022 | 506 | 0.250 |
Why?
|
Humans | 96 | 2024 | 761208 | 0.250 |
Why?
|
Protein-Tyrosine Kinases | 2 | 2016 | 2426 | 0.250 |
Why?
|
Epigenesis, Genetic | 2 | 2020 | 3788 | 0.240 |
Why?
|
Fowlpox virus | 1 | 2024 | 21 | 0.240 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5321 | 0.240 |
Why?
|
Desmoplastic Small Round Cell Tumor | 1 | 2024 | 33 | 0.230 |
Why?
|
Isocitrate Dehydrogenase | 2 | 2021 | 937 | 0.230 |
Why?
|
Transplantation Conditioning | 1 | 2011 | 1591 | 0.230 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2024 | 8530 | 0.230 |
Why?
|
Neoplasm Metastasis | 4 | 2024 | 4909 | 0.230 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2011 | 1372 | 0.220 |
Why?
|
Hodgkin Disease | 1 | 2011 | 1379 | 0.220 |
Why?
|
Middle Aged | 44 | 2024 | 220853 | 0.220 |
Why?
|
Protein Kinase Inhibitors | 9 | 2024 | 5662 | 0.220 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 2 | 2023 | 368 | 0.210 |
Why?
|
Protein Isoforms | 2 | 2024 | 1695 | 0.210 |
Why?
|
Adult | 44 | 2024 | 221119 | 0.210 |
Why?
|
Endosonography | 3 | 2021 | 608 | 0.210 |
Why?
|
Ketones | 1 | 2024 | 182 | 0.210 |
Why?
|
Central Nervous System Neoplasms | 1 | 2011 | 915 | 0.210 |
Why?
|
Tetrahydronaphthalenes | 1 | 2023 | 86 | 0.210 |
Why?
|
Neoplasm Recurrence, Local | 9 | 2023 | 9278 | 0.210 |
Why?
|
Vaccinia virus | 1 | 2024 | 329 | 0.200 |
Why?
|
Solitary Fibrous Tumors | 1 | 2023 | 67 | 0.200 |
Why?
|
Cyclin D1 | 1 | 2024 | 451 | 0.200 |
Why?
|
Ataxia Telangiectasia | 1 | 2023 | 107 | 0.200 |
Why?
|
Aged | 35 | 2024 | 169288 | 0.200 |
Why?
|
Pancreatitis, Chronic | 2 | 2015 | 280 | 0.200 |
Why?
|
Cyclin-Dependent Kinases | 2 | 2017 | 655 | 0.190 |
Why?
|
Fibromatosis, Aggressive | 1 | 2023 | 126 | 0.190 |
Why?
|
Sarcoma, Clear Cell | 1 | 2022 | 72 | 0.190 |
Why?
|
Hemangiosarcoma | 1 | 2024 | 215 | 0.190 |
Why?
|
Skeleton | 1 | 2021 | 29 | 0.190 |
Why?
|
Heterocyclic Compounds, 3-Ring | 1 | 2024 | 287 | 0.190 |
Why?
|
Cell Line, Tumor | 17 | 2024 | 16952 | 0.190 |
Why?
|
Piperazines | 3 | 2024 | 2522 | 0.190 |
Why?
|
Diamines | 1 | 2021 | 60 | 0.190 |
Why?
|
Female | 53 | 2024 | 392544 | 0.180 |
Why?
|
Fibrosarcoma | 1 | 2023 | 308 | 0.180 |
Why?
|
Male | 50 | 2024 | 360693 | 0.180 |
Why?
|
Neoplasms, Second Primary | 2 | 2018 | 1052 | 0.170 |
Why?
|
Skull Base Neoplasms | 1 | 2023 | 270 | 0.170 |
Why?
|
Cell Dedifferentiation | 1 | 2020 | 122 | 0.170 |
Why?
|
Neoplasms | 4 | 2024 | 22140 | 0.170 |
Why?
|
Proto-Oncogene Protein c-fli-1 | 1 | 2020 | 104 | 0.170 |
Why?
|
Receptor Protein-Tyrosine Kinases | 3 | 2023 | 1624 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2023 | 726 | 0.170 |
Why?
|
Pancreatitis, Acute Necrotizing | 1 | 2021 | 171 | 0.160 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13385 | 0.160 |
Why?
|
Leukopenia | 1 | 2019 | 213 | 0.160 |
Why?
|
Survival Analysis | 8 | 2020 | 10088 | 0.160 |
Why?
|
Quinolines | 2 | 2015 | 764 | 0.160 |
Why?
|
High-Throughput Nucleotide Sequencing | 3 | 2021 | 3634 | 0.160 |
Why?
|
Prognosis | 13 | 2023 | 29687 | 0.160 |
Why?
|
Treatment Outcome | 17 | 2024 | 64681 | 0.160 |
Why?
|
Lipopolysaccharides | 2 | 2024 | 2199 | 0.160 |
Why?
|
Hydrogen Peroxide | 2 | 2021 | 731 | 0.160 |
Why?
|
Heart Failure | 2 | 2013 | 11701 | 0.150 |
Why?
|
Endoscopy, Digestive System | 1 | 2021 | 353 | 0.150 |
Why?
|
Leukemia, Radiation-Induced | 1 | 2017 | 39 | 0.150 |
Why?
|
Chromatin | 4 | 2024 | 2946 | 0.150 |
Why?
|
Young Adult | 24 | 2023 | 59221 | 0.150 |
Why?
|
Fractures, Spontaneous | 1 | 2019 | 231 | 0.150 |
Why?
|
Nerve Sheath Neoplasms | 1 | 2019 | 170 | 0.150 |
Why?
|
Phthalazines | 2 | 2023 | 383 | 0.140 |
Why?
|
Chondrosarcoma, Mesenchymal | 1 | 2016 | 12 | 0.140 |
Why?
|
PTEN Phosphohydrolase | 2 | 2014 | 1111 | 0.140 |
Why?
|
Nerve Tissue Proteins | 2 | 2008 | 4404 | 0.140 |
Why?
|
Chromosomes, Human, Pair 14 | 1 | 2017 | 286 | 0.130 |
Why?
|
Sarcoma, Kaposi | 1 | 2019 | 374 | 0.130 |
Why?
|
Duodenum | 1 | 2019 | 491 | 0.130 |
Why?
|
Endothelium, Vascular | 2 | 2005 | 4420 | 0.130 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2020 | 634 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-pim-1 | 1 | 2015 | 32 | 0.130 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 3 | 2020 | 1089 | 0.130 |
Why?
|
Benzylidene Compounds | 1 | 2015 | 25 | 0.130 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2019 | 504 | 0.130 |
Why?
|
Hypoglycemia | 1 | 2023 | 883 | 0.130 |
Why?
|
Piperidines | 2 | 2015 | 1656 | 0.130 |
Why?
|
Antibiotics, Antineoplastic | 3 | 2014 | 677 | 0.130 |
Why?
|
Glioma | 2 | 2021 | 3452 | 0.130 |
Why?
|
Mutation | 8 | 2023 | 30002 | 0.130 |
Why?
|
Gene Regulatory Networks | 2 | 2024 | 1743 | 0.120 |
Why?
|
Paclitaxel | 4 | 2016 | 1730 | 0.120 |
Why?
|
Genomic Imprinting | 1 | 2017 | 323 | 0.120 |
Why?
|
Pyrroles | 1 | 2021 | 1124 | 0.120 |
Why?
|
Deoxycytidine | 1 | 2019 | 878 | 0.120 |
Why?
|
Stomach | 1 | 2019 | 697 | 0.120 |
Why?
|
Neoplasms, Radiation-Induced | 1 | 2019 | 549 | 0.120 |
Why?
|
Pyridones | 1 | 2020 | 809 | 0.120 |
Why?
|
Aptitude | 1 | 2014 | 43 | 0.120 |
Why?
|
Kaplan-Meier Estimate | 3 | 2020 | 6486 | 0.120 |
Why?
|
Neutropenia | 1 | 2019 | 885 | 0.120 |
Why?
|
Uterine Neoplasms | 1 | 2023 | 1420 | 0.120 |
Why?
|
Histone Deacetylase Inhibitors | 2 | 2021 | 774 | 0.120 |
Why?
|
Benzofurans | 1 | 2014 | 139 | 0.110 |
Why?
|
Neurofibromatosis 1 | 1 | 2019 | 561 | 0.110 |
Why?
|
Retrospective Studies | 14 | 2022 | 80674 | 0.110 |
Why?
|
Gene Targeting | 1 | 2017 | 838 | 0.110 |
Why?
|
Molecular Targeted Therapy | 3 | 2021 | 2813 | 0.110 |
Why?
|
Bicarbonates | 1 | 2014 | 292 | 0.110 |
Why?
|
Limb Salvage | 1 | 2016 | 480 | 0.110 |
Why?
|
Retroperitoneal Neoplasms | 1 | 2016 | 333 | 0.110 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2011 | 5666 | 0.110 |
Why?
|
Adolescent | 20 | 2023 | 88298 | 0.100 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2014 | 125 | 0.100 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2017 | 610 | 0.100 |
Why?
|
Phosphatidylinositol 3-Kinases | 5 | 2014 | 2864 | 0.100 |
Why?
|
Disease-Free Survival | 4 | 2023 | 6819 | 0.100 |
Why?
|
Brain Neoplasms | 3 | 2021 | 9025 | 0.100 |
Why?
|
Thiazolidinediones | 1 | 2015 | 460 | 0.100 |
Why?
|
Ovarian Neoplasms | 2 | 2023 | 4872 | 0.100 |
Why?
|
Enzyme Inhibitors | 2 | 2020 | 3702 | 0.100 |
Why?
|
Antibodies | 1 | 2020 | 2415 | 0.100 |
Why?
|
Aged, 80 and over | 13 | 2024 | 58952 | 0.100 |
Why?
|
Cell Membrane Permeability | 1 | 2014 | 573 | 0.100 |
Why?
|
Genes, Neoplasm | 1 | 2014 | 370 | 0.100 |
Why?
|
Bile Ducts, Intrahepatic | 1 | 2013 | 297 | 0.100 |
Why?
|
Pancreatic Ducts | 1 | 2014 | 329 | 0.100 |
Why?
|
Sequence Analysis, RNA | 1 | 2020 | 2011 | 0.100 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2019 | 955 | 0.100 |
Why?
|
Hydroxamic Acids | 1 | 2014 | 479 | 0.100 |
Why?
|
Thiotepa | 1 | 2011 | 66 | 0.100 |
Why?
|
Repressor Proteins | 2 | 2022 | 2974 | 0.100 |
Why?
|
Indomethacin | 1 | 2012 | 322 | 0.100 |
Why?
|
Lysine | 1 | 2016 | 982 | 0.100 |
Why?
|
Cell Proliferation | 3 | 2020 | 10422 | 0.090 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2014 | 450 | 0.090 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 1855 | 0.090 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2014 | 697 | 0.090 |
Why?
|
Child | 17 | 2023 | 80152 | 0.090 |
Why?
|
Receptors, Androgen | 1 | 2017 | 1077 | 0.090 |
Why?
|
Busulfan | 1 | 2011 | 258 | 0.090 |
Why?
|
Carcinoma | 1 | 2022 | 2330 | 0.090 |
Why?
|
Recombinant Fusion Proteins | 1 | 2019 | 3726 | 0.090 |
Why?
|
Drug Synergism | 4 | 2015 | 1756 | 0.090 |
Why?
|
Neoplasm Staging | 5 | 2023 | 11119 | 0.090 |
Why?
|
Histones | 2 | 2020 | 2570 | 0.090 |
Why?
|
Anilides | 2 | 2023 | 411 | 0.080 |
Why?
|
Phosphoprotein Phosphatases | 1 | 2011 | 328 | 0.080 |
Why?
|
Oncogenes | 3 | 2022 | 1220 | 0.080 |
Why?
|
Chromosome Deletion | 1 | 2014 | 1386 | 0.080 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2014 | 725 | 0.080 |
Why?
|
Tissue Array Analysis | 3 | 2016 | 550 | 0.080 |
Why?
|
Palmitates | 1 | 2008 | 70 | 0.080 |
Why?
|
Analgesics | 1 | 2015 | 1068 | 0.080 |
Why?
|
Immunohistochemistry | 5 | 2023 | 11067 | 0.080 |
Why?
|
Kidney Medulla | 1 | 1989 | 169 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2023 | 3163 | 0.080 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2017 | 1549 | 0.080 |
Why?
|
Follow-Up Studies | 7 | 2023 | 39126 | 0.080 |
Why?
|
Myofibrils | 1 | 2009 | 142 | 0.080 |
Why?
|
Myelodysplastic Syndromes | 1 | 2018 | 1393 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 1 | 2016 | 1967 | 0.070 |
Why?
|
Cholangiocarcinoma | 1 | 2013 | 554 | 0.070 |
Why?
|
Gastroenterology | 1 | 2014 | 580 | 0.070 |
Why?
|
Bile Duct Neoplasms | 1 | 2013 | 607 | 0.070 |
Why?
|
Protons | 2 | 2023 | 1111 | 0.070 |
Why?
|
Cell Movement | 2 | 2016 | 5195 | 0.070 |
Why?
|
Binding Sites | 3 | 2023 | 5988 | 0.070 |
Why?
|
Pancreas | 1 | 2014 | 1684 | 0.070 |
Why?
|
Kidney Neoplasms | 1 | 2023 | 4251 | 0.070 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2024 | 3592 | 0.070 |
Why?
|
RNA Interference | 1 | 2015 | 2816 | 0.070 |
Why?
|
Sequence Analysis, DNA | 2 | 2017 | 4739 | 0.070 |
Why?
|
Clinical Trials as Topic | 2 | 2013 | 8003 | 0.070 |
Why?
|
Transplantation, Autologous | 1 | 2011 | 2112 | 0.070 |
Why?
|
Risk | 1 | 2018 | 9616 | 0.070 |
Why?
|
Myocardium | 2 | 2012 | 4746 | 0.070 |
Why?
|
Radiotherapy Dosage | 3 | 2018 | 2897 | 0.070 |
Why?
|
Gastrointestinal Diseases | 1 | 2014 | 1201 | 0.060 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2017 | 1726 | 0.060 |
Why?
|
Hypercalcemia | 1 | 1989 | 423 | 0.060 |
Why?
|
Nuclear Proteins | 3 | 2022 | 5782 | 0.060 |
Why?
|
Animals | 14 | 2024 | 168079 | 0.060 |
Why?
|
Oleic Acid | 1 | 2005 | 92 | 0.060 |
Why?
|
Cyclophosphamide | 1 | 2011 | 2219 | 0.060 |
Why?
|
Child, Preschool | 8 | 2023 | 42224 | 0.060 |
Why?
|
Rats | 6 | 2024 | 23704 | 0.060 |
Why?
|
Palmitic Acid | 1 | 2005 | 149 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4642 | 0.060 |
Why?
|
Cystic Fibrosis | 1 | 2014 | 1283 | 0.060 |
Why?
|
Preoperative Care | 1 | 2013 | 2241 | 0.060 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2014 | 2455 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2023 | 2915 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 1 | 2005 | 471 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 4 | 2024 | 10756 | 0.060 |
Why?
|
Pyrazoles | 1 | 2014 | 2010 | 0.060 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 2005 | 475 | 0.060 |
Why?
|
Research Design | 1 | 2019 | 6180 | 0.060 |
Why?
|
WT1 Proteins | 1 | 2024 | 184 | 0.060 |
Why?
|
Tumor Cells, Cultured | 3 | 2017 | 6124 | 0.050 |
Why?
|
Radiotherapy, Adjuvant | 3 | 2016 | 1784 | 0.050 |
Why?
|
Face | 1 | 1989 | 1025 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2011 | 2444 | 0.050 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2270 | 0.050 |
Why?
|
Recombinant Proteins | 3 | 2008 | 6504 | 0.050 |
Why?
|
Bilirubin | 1 | 2024 | 436 | 0.050 |
Why?
|
Apoptosis | 5 | 2014 | 9477 | 0.050 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2017 | 3609 | 0.050 |
Why?
|
DNA-Binding Proteins | 2 | 2020 | 9566 | 0.050 |
Why?
|
Neoplasm Proteins | 3 | 2022 | 3594 | 0.050 |
Why?
|
Valine | 1 | 2023 | 408 | 0.050 |
Why?
|
Carcinoma, Medullary | 2 | 1999 | 115 | 0.050 |
Why?
|
Tumor Suppressor Proteins | 1 | 2011 | 2803 | 0.050 |
Why?
|
Carboplatin | 1 | 2024 | 793 | 0.050 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2023 | 628 | 0.040 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 2 | 1999 | 40 | 0.040 |
Why?
|
Antineoplastic Agents, Phytogenic | 2 | 2015 | 620 | 0.040 |
Why?
|
Skull Base | 1 | 2023 | 292 | 0.040 |
Why?
|
Cells, Cultured | 5 | 2009 | 18926 | 0.040 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2023 | 2058 | 0.040 |
Why?
|
Pain | 1 | 2015 | 5072 | 0.040 |
Why?
|
Alternative Splicing | 1 | 2005 | 1087 | 0.040 |
Why?
|
Gene Knockdown Techniques | 2 | 2016 | 1602 | 0.040 |
Why?
|
Sacrum | 1 | 2022 | 275 | 0.040 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2017 | 2509 | 0.040 |
Why?
|
Calcinosis | 1 | 1989 | 1477 | 0.040 |
Why?
|
Gene Expression | 4 | 2017 | 7571 | 0.040 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2014 | 899 | 0.040 |
Why?
|
Transcription Factors | 2 | 2022 | 12099 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2022 | 316 | 0.040 |
Why?
|
Pancreatic Neoplasms | 1 | 2017 | 5366 | 0.040 |
Why?
|
Tumor Microenvironment | 2 | 2024 | 3873 | 0.040 |
Why?
|
Mice, Nude | 2 | 2016 | 3605 | 0.040 |
Why?
|
ROC Curve | 2 | 2017 | 3584 | 0.040 |
Why?
|
Florida | 1 | 2020 | 429 | 0.040 |
Why?
|
Infant | 5 | 2023 | 36169 | 0.040 |
Why?
|
Dogs | 1 | 2024 | 3832 | 0.040 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2020 | 4574 | 0.040 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2023 | 619 | 0.040 |
Why?
|
Anti-Infective Agents, Local | 1 | 2021 | 247 | 0.040 |
Why?
|
Neoadjuvant Therapy | 2 | 2022 | 2827 | 0.040 |
Why?
|
Ligands | 1 | 2005 | 3264 | 0.040 |
Why?
|
Signal Transduction | 5 | 2014 | 23416 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 2 | 2008 | 8164 | 0.040 |
Why?
|
Necrosis | 1 | 2022 | 1610 | 0.040 |
Why?
|
Spheroids, Cellular | 1 | 2020 | 329 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2020 | 9416 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1702 | 0.040 |
Why?
|
Protein Stability | 1 | 2020 | 579 | 0.040 |
Why?
|
Cell Cycle Proteins | 2 | 2022 | 3446 | 0.040 |
Why?
|
Leukemia, Monocytic, Acute | 1 | 2017 | 58 | 0.040 |
Why?
|
RNA Stability | 1 | 2020 | 317 | 0.040 |
Why?
|
Biopsy | 2 | 2020 | 6781 | 0.040 |
Why?
|
Cell Survival | 3 | 2016 | 5778 | 0.040 |
Why?
|
Workflow | 1 | 2022 | 850 | 0.040 |
Why?
|
Aminopyridines | 1 | 2021 | 573 | 0.040 |
Why?
|
RNA, Messenger | 3 | 2020 | 12747 | 0.040 |
Why?
|
Phenotype | 4 | 2020 | 16575 | 0.040 |
Why?
|
Morpholines | 1 | 2020 | 581 | 0.040 |
Why?
|
Utah | 1 | 2017 | 130 | 0.040 |
Why?
|
Down-Regulation | 2 | 2015 | 2916 | 0.040 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2004 | 1783 | 0.040 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2021 | 559 | 0.030 |
Why?
|
Morbidity | 1 | 2022 | 1751 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14675 | 0.030 |
Why?
|
Mice | 8 | 2024 | 81326 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2004 | 2138 | 0.030 |
Why?
|
Clone Cells | 1 | 2020 | 1668 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2021 | 716 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2004 | 1985 | 0.030 |
Why?
|
Aortic Valve Stenosis | 1 | 1989 | 2018 | 0.030 |
Why?
|
Glioblastoma | 1 | 2011 | 3482 | 0.030 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2019 | 662 | 0.030 |
Why?
|
Boston | 2 | 2020 | 9327 | 0.030 |
Why?
|
Double-Blind Method | 3 | 2023 | 12341 | 0.030 |
Why?
|
Biphenyl Compounds | 1 | 2020 | 1007 | 0.030 |
Why?
|
DNA Methylation | 2 | 2022 | 4384 | 0.030 |
Why?
|
Ultrasonography | 1 | 1989 | 5969 | 0.030 |
Why?
|
Drainage | 1 | 2021 | 1157 | 0.030 |
Why?
|
Cell Lineage | 1 | 2004 | 2548 | 0.030 |
Why?
|
Protein Transport | 1 | 2020 | 1958 | 0.030 |
Why?
|
Organoids | 1 | 2020 | 744 | 0.030 |
Why?
|
Oxidative Stress | 1 | 2005 | 3114 | 0.030 |
Why?
|
Phosphorylation | 1 | 2005 | 8300 | 0.030 |
Why?
|
Multiprotein Complexes | 1 | 2020 | 1112 | 0.030 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 1997 | 323 | 0.030 |
Why?
|
mRNA Cleavage and Polyadenylation Factors | 1 | 2014 | 105 | 0.030 |
Why?
|
Coronary Vessels | 1 | 2005 | 3111 | 0.030 |
Why?
|
Gene Knockout Techniques | 1 | 2017 | 801 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2017 | 748 | 0.030 |
Why?
|
Deglutition Disorders | 1 | 2019 | 627 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2023 | 11509 | 0.030 |
Why?
|
Glucose | 1 | 2005 | 4342 | 0.030 |
Why?
|
CD4 Lymphocyte Count | 1 | 2019 | 2569 | 0.030 |
Why?
|
Methylation | 1 | 2016 | 1070 | 0.030 |
Why?
|
DNA Damage | 1 | 2023 | 2442 | 0.030 |
Why?
|
Peptide Library | 1 | 2014 | 347 | 0.030 |
Why?
|
Blotting, Western | 2 | 2015 | 5032 | 0.030 |
Why?
|
Survival Rate | 2 | 2019 | 12728 | 0.030 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2019 | 876 | 0.030 |
Why?
|
Abdominal Pain | 1 | 2019 | 1067 | 0.030 |
Why?
|
Area Under Curve | 1 | 2017 | 1636 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2015 | 514 | 0.030 |
Why?
|
Retreatment | 1 | 2014 | 598 | 0.030 |
Why?
|
Learning Curve | 1 | 2014 | 230 | 0.030 |
Why?
|
Sphincter of Oddi Dysfunction | 1 | 2012 | 5 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 1997 | 1822 | 0.030 |
Why?
|
SEER Program | 1 | 2017 | 1453 | 0.030 |
Why?
|
Administration, Rectal | 1 | 2012 | 69 | 0.030 |
Why?
|
Dilatation, Pathologic | 1 | 2014 | 527 | 0.030 |
Why?
|
Kinetics | 1 | 2020 | 6312 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2015 | 1703 | 0.020 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2014 | 629 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2017 | 2928 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2014 | 535 | 0.020 |
Why?
|
DNA, Neoplasm | 1 | 2017 | 1743 | 0.020 |
Why?
|
Acute Disease | 1 | 2022 | 7226 | 0.020 |
Why?
|
Dyspnea | 1 | 2019 | 1347 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2004 | 4372 | 0.020 |
Why?
|
Chlorides | 1 | 2014 | 657 | 0.020 |
Why?
|
Disease Progression | 2 | 2021 | 13511 | 0.020 |
Why?
|
Lipoma | 1 | 2013 | 293 | 0.020 |
Why?
|
Molecular Dynamics Simulation | 1 | 2014 | 427 | 0.020 |
Why?
|
Quality of Life | 2 | 2023 | 13367 | 0.020 |
Why?
|
Fish Oils | 1 | 1994 | 483 | 0.020 |
Why?
|
GTP Phosphohydrolases | 1 | 2014 | 517 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2320 | 0.020 |
Why?
|
Prospective Studies | 4 | 2022 | 54435 | 0.020 |
Why?
|
Islets of Langerhans | 1 | 1997 | 1342 | 0.020 |
Why?
|
Hepatectomy | 1 | 2013 | 557 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2016 | 931 | 0.020 |
Why?
|
Pancreaticoduodenectomy | 1 | 2013 | 509 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2014 | 566 | 0.020 |
Why?
|
Reproduction | 1 | 2014 | 646 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2451 | 0.020 |
Why?
|
Proto-Oncogene Proteins | 2 | 2004 | 4513 | 0.020 |
Why?
|
Enzyme Activation | 2 | 2005 | 3577 | 0.020 |
Why?
|
beta Catenin | 1 | 2014 | 1042 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2017 | 3590 | 0.020 |
Why?
|
Gene Silencing | 1 | 2015 | 1495 | 0.020 |
Why?
|
Postoperative Period | 1 | 2013 | 1818 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9297 | 0.020 |
Why?
|
Treatment Failure | 1 | 2014 | 2643 | 0.020 |
Why?
|
GATA4 Transcription Factor | 1 | 2009 | 124 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7033 | 0.020 |
Why?
|
Thyroid Neoplasms | 2 | 1999 | 2330 | 0.020 |
Why?
|
DNA | 1 | 2022 | 7189 | 0.020 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2016 | 3512 | 0.020 |
Why?
|
Cisplatin | 1 | 2014 | 1652 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6067 | 0.020 |
Why?
|
Angioplasty, Balloon, Coronary | 1 | 1994 | 1724 | 0.020 |
Why?
|
Drosophila Proteins | 1 | 1996 | 1696 | 0.020 |
Why?
|
Fibrosis | 1 | 2014 | 2051 | 0.020 |
Why?
|
Administration, Oral | 1 | 2014 | 4015 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2014 | 4851 | 0.020 |
Why?
|
Risk Factors | 3 | 2022 | 74239 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2009 | 614 | 0.020 |
Why?
|
Skin | 1 | 2019 | 4473 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2014 | 4107 | 0.020 |
Why?
|
Recurrence | 2 | 2014 | 8457 | 0.020 |
Why?
|
Rats, Wistar | 1 | 2009 | 1848 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 4243 | 0.020 |
Why?
|
Phenanthrolines | 1 | 2004 | 49 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2014 | 2731 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2022 | 5333 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 12976 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2013 | 3412 | 0.010 |
Why?
|
Base Sequence | 1 | 2015 | 12404 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2011 | 20982 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10553 | 0.010 |
Why?
|
Myocardial Contraction | 1 | 2009 | 1516 | 0.010 |
Why?
|
Muscle Proteins | 1 | 2009 | 1149 | 0.010 |
Why?
|
Cell Death | 1 | 2009 | 1676 | 0.010 |
Why?
|
In Situ Nick-End Labeling | 1 | 2004 | 613 | 0.010 |
Why?
|
Lung | 1 | 2022 | 9979 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2017 | 7571 | 0.010 |
Why?
|
Culture Media, Conditioned | 1 | 2004 | 522 | 0.010 |
Why?
|
Massachusetts | 1 | 2016 | 8837 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12474 | 0.010 |
Why?
|
Syndrome | 1 | 1989 | 3271 | 0.010 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 1997 | 3417 | 0.010 |
Why?
|
Immunoprecipitation | 1 | 2004 | 874 | 0.010 |
Why?
|
Liver Transplantation | 1 | 2013 | 2332 | 0.010 |
Why?
|
Adoptive Transfer | 1 | 2004 | 823 | 0.010 |
Why?
|
Cross-Linking Reagents | 1 | 2004 | 684 | 0.010 |
Why?
|
Immunoblotting | 1 | 2004 | 1644 | 0.010 |
Why?
|
Databases, Factual | 1 | 2016 | 7966 | 0.010 |
Why?
|
Age Factors | 1 | 2017 | 18384 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2005 | 1240 | 0.010 |
Why?
|
Coculture Techniques | 1 | 2004 | 1334 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2013 | 12052 | 0.010 |
Why?
|
Coronary Disease | 1 | 1994 | 5921 | 0.010 |
Why?
|
Immunization | 1 | 2004 | 1218 | 0.010 |
Why?
|
Genotype | 1 | 2014 | 12985 | 0.010 |
Why?
|
Perfusion | 1 | 2004 | 1390 | 0.010 |
Why?
|
Microcirculation | 1 | 2004 | 1280 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 22174 | 0.010 |
Why?
|
Multiple Endocrine Neoplasia Type 2b | 1 | 1999 | 10 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 21365 | 0.010 |
Why?
|
Models, Biological | 1 | 2015 | 9457 | 0.010 |
Why?
|
Clinical Competence | 1 | 2014 | 4788 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17897 | 0.010 |
Why?
|
Mice, Transgenic | 2 | 2004 | 9520 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2015 | 7400 | 0.010 |
Why?
|
Length of Stay | 1 | 2012 | 6417 | 0.010 |
Why?
|
Immunity | 1 | 2004 | 996 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2018 | 26199 | 0.010 |
Why?
|
Prevalence | 1 | 2015 | 15721 | 0.010 |
Why?
|
Reperfusion Injury | 1 | 2004 | 1026 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2004 | 1348 | 0.010 |
Why?
|
Calcitonin | 1 | 1999 | 329 | 0.010 |
Why?
|
Neck Dissection | 1 | 1999 | 201 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2014 | 7851 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 41496 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2014 | 20119 | 0.010 |
Why?
|
Calcium | 1 | 2009 | 5719 | 0.010 |
Why?
|
Mitochondria | 1 | 2009 | 3620 | 0.010 |
Why?
|
Hyperparathyroidism | 1 | 1996 | 337 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 1996 | 225 | 0.010 |
Why?
|
Codon | 1 | 1996 | 597 | 0.010 |
Why?
|
Hirschsprung Disease | 1 | 1996 | 163 | 0.010 |
Why?
|
Pheochromocytoma | 1 | 1996 | 328 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2004 | 5478 | 0.010 |
Why?
|
HIV Infections | 1 | 2019 | 17347 | 0.010 |
Why?
|
Thyroidectomy | 1 | 1999 | 908 | 0.010 |
Why?
|
Hospitalization | 1 | 2012 | 10707 | 0.010 |
Why?
|
Cysteine | 1 | 1996 | 888 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2004 | 14392 | 0.000 |
Why?
|
Mice, Inbred C57BL | 1 | 2004 | 22127 | 0.000 |
Why?
|
Immunosuppressive Agents | 1 | 1997 | 4190 | 0.000 |
Why?
|
B-Lymphocytes | 1 | 1997 | 4744 | 0.000 |
Why?
|
Cell Line | 1 | 1997 | 15545 | 0.000 |
Why?
|
Time Factors | 1 | 2004 | 39957 | 0.000 |
Why?
|
Insulin | 1 | 1997 | 6588 | 0.000 |
Why?
|
T-Lymphocytes | 1 | 1997 | 10203 | 0.000 |
Why?
|
Smoking | 1 | 1994 | 9055 | 0.000 |
Why?
|